ProsTIC Preceptorship 2022
From Melbourne to the World
Held 1st - 2nd April 2022

 

Accessing ProsTIC Preceptorship 2022 – On Demand Presentations

Preceptorship themes

PSMA PET/CT

What is the role of PSMA PET/CT in early stage prostate cancer?

Evidence

Evidence-based PSMA​

Biomarkers

Is PSMA PET/CT a new biomarker for optimising patient management?

Advocates

Consumer advocates

Theranostic Suite

The Theranostic Suite: How we run it from 5 perspectives

PSMA Theranostics

The art of PSMA theranostics​

Welcome

It is with delight and pleasure that I invite, and warmly welcome you to the inaugural ProsTIC Preceptorship 2022, in-person or online.

In line with one of our program’s key pillars of Education and Leadership, we are proud to present “How we do PSMA Theranostics”.

Together with multidisciplinary colleagues and world leading experts we will provide you with the latest in research, case studies, practical applications and the future of PSMA Imaging and Theranostics.  

We performed our first PSMA PET/CT in 2014, and our first Lutetium PSMA therapy in 2015. We will share with you how we, at the Peter MacCallum Cancer Centre, “do” our successful program, so you can too!

Kind regards,

Professor Michael Hofman
Chair, ProsTIC Preceptorship 2022
Director, Prostate Cancer Theranostics and Imaging Centre of Excellence

Preceptorship Updates

Session 1: What is the role of PSMA PET/CT in early stage prostate cancer
Friday 1st April
8:30am – 10:30am

Our stellar program opens with a deep dive into the role of PSMA PET/CT in early-stage prostate cancer. Prof Wolfgang Fendler and Prof Thomas Hope support our local experts including Prof. Louise Emmett.
Session 3: Evidence-based PSMA radioligand therapy
Friday 1st April
1:30pm – 3:30pm

From TheraP to treatment combination trials, join experts Prof Silke Gillessen and A/Prof Shahneen Sandhu to provide insights on how we utilise PSMA radioligand therapy.
Session 4: The Theranostic Suite: how we run it from 7 perspectives
Friday 1st April
4:00pm – 5:30pm

For behind the scenes action on how the Peter Mac team run a theranostics suite, we explore all of the multidisciplinary perspectives.
Session 5: The art of PSMA theranostics
Saturday 2nd April
8:00am – 9:00am

Go beyond the images and discover what’s around the corner for PSMA theranostics with Dr Heidi Fettke and Dr Andrei Gafita.
Session 7: The Barry Elderfield Lecture
Saturday 2nd April
11.00am – 12.30pm

In a world first, join Professor Thomas Hope, Professor Michael Hofman and Professor Declan Murphy, as they HARDtalk the hot topics and hard hitting questions of “The current state of PSMA” and “What’s coming next”.
Previous
Next

SPONSORS

Accelerate clinical trial research

Accelerate clinical trial research

Expand the portfolio of clinical trials investigating the use of PSMA PET imaging and therapy targeting areas of high-impact need that are not currently being addressed.

Education & Leadership

Education & Leadership

Establish a global hub of excellence to educate doctors, scientists, patients and the community about the application and benefits of this new technology.

Discovery research

Discovery research

Further investigate next generation targets, develop biomarkers to predict and monitor response to PSMA therapy, optimise new combinations with PSMA therapy in pre-clinical models, explore the use of radio-guided surgery and artificial intelligence image interpretation.